Johnson & Johnson Posts Disappointing Sales, Guidance

Johnson & Johnson (JNJ) reported adjusted fourth quarter earnings of $1.03 per share this morning, matching the consensus analyst estimate. But revenue of $15.6 billion came up well short of Wall Street’s expectations, and the company’s 2011 guidance disappointed as well, sending shares down in pre-market trading. Analysts were expecting the health care giant to [...]